This is “Hot Topics” news related category.

LCA Joins ACS CAN in Efforts to Protect Patient Access to Lifesaving Treatment

2019-01-17T20:05:01+00:00January 17th, 2019|Hot Topics, News|

Thursday, January 17 – Lung Cancer Alliance joins a long list of leading patient advocacy groups in support of American Cancer Society Cancer Action Network’s (ASC CAN) advertising campaign, urging the U.S. Administration and Congress not to limit patient access to lifesaving medications covered under Medicare, and to ensure the Six Protected Classes policy is preserved. The Six Protected Classes policy offers patients access to cutting-edge FDA-approved therapies for epilepsy, mental illness, cancer, HIV-Aids and organ transplants. A proposal from [...]

Don’t Guess, Test!

2019-01-17T15:14:18+00:00January 17th, 2019|Hot Topics, Stories of Hope|

By Kimberly Buchmeier My name is Kimberly Buchmeier and I am from a small town in Southeast Nebraska.  I am a mother, wife, grandmother, daughter, sister, aunt, cousin, friend and a six-year lung cancer survivor.  In 2011, at age 37, I was diagnosed with non-small cell adenocarcinoma. I thought I was pretty healthy. I ran a half marathon the year before, exercise on a regular basis and am not overweight.  With three active kids at home and a full [...]

New Year, New You!

2019-01-03T17:12:54+00:00January 3rd, 2019|Hot Topics|

Goodbye 2018, hello 2019! With the new year comes new opportunity to recommit to your health and well-being. If you’re part of the 41% of Americans looking to set a New Year resolution, we can help! Here are four worthy commitments to consider this year. FIND SUPPORT: Support in your lung cancer journey is beneficial whether you’re a twenty-year survivor, newly diagnosed or caring for a loved one. Get involved with our peer-to-peer support programs: Phone Buddy for patients and survivors [...]

Get Well Soon Justice Ginsburg

2018-12-21T21:38:16+00:00December 21st, 2018|Hot Topics, News|

On behalf of the lung cancer community we serve, we send our best wishes for a speedy recovery to Supreme Court Justice Ruth Bader Ginsburg. According to a Supreme Court press release, Justice Ginsburg is now resting comfortably after undergoing a pulmonary lobectomy today. Two nodules, found to be malignant on initial pathology evaluation, were removed. The nodules were incidental findings from tests used to diagnose and treat Justice Ginsburg’s recent rib fractures from a November 7 fall. “We are relieved [...]

A Message from LCA’s President

2018-12-19T16:31:37+00:00December 19th, 2018|Hot Topics, News|

To the Lung Cancer Community, As 2018 prepares to come to a close, let’s take this moment to reflect upon what we have accomplished to improve survivorship, provide support and bring our community together in a lasting and meaningful way. Together we secured millions more dollars in federal research funding, helped hundreds of patients navigate clinical trials and get molecular testing, launched a screening campaign to help people talk with their physicians about lung cancer screening and their risk, enhanced [...]

Giving—Why Not?

2018-12-12T20:58:50+00:00December 12th, 2018|Hot Topics|

With the season of giving upon us, now is the perfect time to join the fight against lung cancer. Over 234,000 people were diagnosed with lung cancer this year, making it the leading cause of cancer death for both men and women across all ethnicities. You can help us continue the important work of offering support, information and resources to those impacted by the disease by donating to Lung Cancer Alliance today. There is still time to make a meaningful [...]

New Combination Treatment Approved for Non-Small Cell Lung Cancer

2018-12-07T14:39:55+00:00December 7th, 2018|Hot Topics, News|

The Food and Drug Administration (FDA) approved atezolizumab (TECENTRIQ®), an immunotherapy drug, in combination with bevacizumab, paclitaxel, and carboplatin for the first-line treatment of patients with metastatic non-squamous, non-small cell lung cancer (NSq NSCLC) with no EGFR or ALK genomic tumor aberrations. This is the first four drug combination treatment approved for lung cancer. Click here to learn more.

LCA partners with GRAIL, UCL, and ULCH on Newly Announced SUMMIT Study

2018-12-04T00:24:30+00:00December 4th, 2018|Hot Topics, News|

Monday, December 3, 2018 –Today, Lung Cancer Alliance, in collaboration with GRAIL, Inc., a healthcare company focused on the early detection of cancer, UCL (University College London) and University College London Hospitals National Health Service (NHS) Foundation Trust (UCLH) announced plans to initiate the SUMMIT study in early 2019. SUMMIT, which will be conducted in the United Kingdom, is a prospective, observational, longitudinal, cohort study designed to enroll approximately 50,000 men and women age 50 to 77 years who do [...]